


Pharmaceuticals & Biotechnology | Small Cap
Windlas Biotech demonstrates a mixed financial performance. The company shows strong solvency, growth, coverage, and profitability. It maintains a very low level of debt and robust growth in revenue, operating profit, and earnings per share, alongside excellent interest and dividend coverage. Profitability metrics such as gross profit margin, ROCE, ROE, ROA, and operating and net margins are also very strong. However, there are concerns regarding liquidity and efficiency. The company's liquidity ratios suggest challenges in meeting short-term obligations, while efficiency ratios indicate potential issues with asset utilization, particularly in fixed assets and capital turnover. Financial ratios also present some weaknesses. Overall, Windlas Biotech exhibits solid financial health driven by growth and profitability, but needs to address areas related to liquidity and efficiency to ensure long-term stability and performance.
Windlas Biotech demonstrates a mixed financial performance. The company shows strong solvency, growth, coverage, and profitability. It maintains a very low level of debt and robust growth in revenue, operating profit, and earnings per share, alongside excellent interest and dividend coverage. Profitability metrics such as gross profit margin, ROCE, ROE, ROA, and operating and net margins are also very strong. However, there are concerns regarding liquidity and efficiency. The company's liquidity ratios suggest challenges in meeting short-term obligations, while efficiency ratios indicate potential issues with asset utilization, particularly in fixed assets and capital turnover. Financial ratios also present some weaknesses. Overall, Windlas Biotech exhibits solid financial health driven by growth and profitability, but needs to address areas related to liquidity and efficiency to ensure long-term stability and performance.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
27.14
Industry Median
30.92
Small Cap Median
28.82
P/E RATIO
27.76
P/B RATIO
3.18
Industry Median
3.39
Small Cap Median
2.92
P/S RATIO
1.96
Industry Median
3.36
Small Cap Median
2.72
Others
PEG RATIO
0.00
EV/EBITDA RATIO
14.45
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹873.75 as on Aug 6, 2026.
The company exhibits excellent growth across all key metrics. Strong revenue growth, operating profit growth, EPS growth, asset growth, and net income growth reflect robust business expansion and effective management strategies. This indicates a positive trajectory and strong potential for future performance. The company is effectively scaling its operations and profitability.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 8.88 | 10.09 | 23 | 20.44 | 18.95 |
| Operating Profit Growth Rate | -3.64 | 13.21 | 30 | 20.51 | 11.7 |
| Earnings Per Share (EPS) Growth | 126.5 | 13.34 | 39.4 | 3.54 | 8.78 |
| Asset Growth Rate | 65.88 | 7.74 | 18.34 | 21.41 | 19.34 |
| Net Income Growth Rate | 680 | 10.26 | 34.88 | 5.17 | 8.2 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jagsonpal Pharmaceuticals Ltd | 8.51 | 37.02 | Overvalued | 58.00 | 6.54 | 43.00 |
| 2 | Amrutanjan Health Care Ltd | 8.25 | 73.76 | Highly Overvalued | 31.00 | 20.03 | 21.00 |
| 3 | Accent Microcell Ltd | 7.96 | 24.25 | Neutral | 57.00 | 18.28 | 44.00 |
| 4 | Windlas Biotech Ltd | 7.52 | 27.76 | Neutral | 105.00 | 32.19 | 66.00 |
| 5 | Lincoln Pharmaceuticals Ltd | 7.31 | 13.81 | Neutral | 98.00 | 43.88 | 88.00 |
| 6 | Morepen Laboratories Ltd | 7.12 | 45.91 | Neutral | 126.00 | 1.21 | 96.00 |
| 7 | Alembic Ltd | 7.06 | 7.01 | Undervalued | 90.00 | 4.85 | 317.00 |
| 8 | NGL Fine Chem Ltd | 6.98 | 44.01 | Overvalued | 73.00 | 67.39 | 48.00 |
| 9 | Syncom Formulations (India) Ltd | 6.92 | 16.27 | Undervalued | 77.00 | 0.81 | 76.00 |
| 10 | Sakar Healthcare Ltd | 6.89 | 67.13 | Highly Overvalued | 69.00 | 13.70 | 30.00 |
| 11 | Hester Biosciences Ltd | 6.54 | 37.59 | Neutral | 87.00 | 61.24 | 57.00 |
| 12 | Sigachi Industries Ltd | 6.49 | 11.55 | Highly Undervalued | 54.00 | -2.08 | -83.00 |
| 13 | Remus Pharmaceuticals Ltd | 5.31 | 25.82 | Neutral | 57.00 | 20.97 | 46.00 |
| 14 | IOL Chemicals & Pharmaceuticals Ltd | 5.31 | 34.79 | Undervalued | 269.00 | 4.69 | 138.00 |
| 15 | Indoco Remedies Ltd | 5.26 | -21.52 | Neutral | 142.00 | -0.61 | -99.00 |
| 16 | Ind-Swift Laboratories Ltd | 4.95 | 47.48 | Neutral | 45.00 | 4.89 | 41.00 |
| 17 | Venus Remedies Ltd | 4.83 | 23.37 | Neutral | 147.00 | 74.30 | 103.00 |
| 18 | Wanbury Ltd | 4.65 | 29.43 | Neutral | 88.00 | 18.93 | 43.00 |
| 19 | Solara Active Pharma Sciences Ltd | 4.34 | -249.32 | Neutral | 187.00 | -1.50 | -7.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral